1-3 of 3
J. Hainsworth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

Owen A O'Connor, J. Gerecitano, H. Van Deventer, B. Afanasyev, J. Hainsworth, M. Chen, K. Saikali, J. Seroogy, R. Escandon, A. Wolff, MG. Conlan
Journal: Blood
Blood (2009) 114 (22): 1673.
https://doi.org/10.1182/blood.V114.22.1673.1673
Published: 2009
Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff
Journal: Blood
Blood (2008) 112 (11): 1563.
https://doi.org/10.1182/blood.V112.11.1563.1563
Published: 2008
Journal Articles

A Phase I-II Study To Determine the Safety, Pharmacokinetics and Potential Efficacy of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 on Days 1 and 15 of a 28 Day Schedule in Patients with Non-Hodgkin’s or Hodgkin’s Lymphoma.

Owen A. O’Connor, A. Goy, R.Z. Orlowski, J. Hainsworth, J.P. Leonard, B. Afanasyev, D. Osmanov, L.M. Reyno, M.M. Chen, R.D. Escandon
Journal: Blood
Blood (2007) 110 (11): 2556.
https://doi.org/10.1182/blood.V110.11.2556.2556
Published: 2007